Skinbiotherapeutics Price: SBTX Is on a Rise, Facing Barriers at 20

PUBLISHED: Feb 08 2025 @ 06:33 | Comments (0) | More info about Azeez Mustapha

Indicators have been showcasing that bears have been losing stances systemically as the exchange of Skinbiotherapeutics Plc (LSE:SBTX) is on a rising move, tending to face barriers around 20 in the near time if bulls hold further firmly.

The stock market is currently trading around 18.50, exhibiting a mild reversal that lacks strong momentum for sustained upside movement in the near term. Given this weak price action, initiating fresh long positions from the current trade zone is not technically advisable. Investors are encouraged to remain on the sidelines for now.

Resistance Levels: 20, 22, 24
Support Levels: 16, 15, 14

As the oscillators feature in the overbought region, should the SBTX Plc stockholders attempt further moves?

As it has been psychologically observed, it is not ideally okay for investors to resort to furthering fresh orders in the exchanges of Skinbiotherapeutics Plc Shares Company, as the price is on a rising mode, facing barriers at 20.

The 15-day EMA is currently positioned above the 50-day EMA, with a bearish candlestick formation signaling caution for new buy orders. The stochastic oscillators are in the overbought region, raising concerns for buyers. It is advisable to either consolidate existing positions or hold off on entering new trades for the time being.

Learn from market wizards: Books to take your trading to the next

CLICK HERE TO REGISTER FOR FREE ON ADVFN, the world's leading stocks and shares information website, provides the private investor with all the latest high-tech trading tools and includes live price data streaming, stock quotes and the option to access 'Level 2' data on all of the world's key exchanges (LSE, NYSE, NASDAQ, Euronext etc).

Follow @ItuGlobal

This area of the ADVFN.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ADVFN Ltd. ADVFN Ltd does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ADVFN.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ADVFN.COM and is not intended to be relied upon by users in making (or refraining from making) any investment decisions. Authors may or may not have positions in stocks that they are discussing but it should be considered very likely that their opinions are aligned with their trading and that they hold positions in companies, forex, commodities and other instruments they discuss.